Table 5.
Omitting study | PGSK3B | PVEGFA | PPTK2 | PRAP1B | PPIK3CG |
---|---|---|---|---|---|
Omitting Study 1 | 2.16*10-6 | 0.023 | 9.22*10-4 | 0.067 | 0.165 |
Omitting Study 2 | 1.88*10-4 | 0.023 | 9.22*10-4 | 0.067 | 0.489 |
Omitting Study 3 | 2.16*10-6 | 7.55*10-4 | 9.51*10-4 | 0.067 | 0.367 |
Omitting Study 4 | 2.16*10-6 | 0.022 | 9.51*10-4 | 0.023 | 0.165 |
Omitting Study 5 | 1.88*10-4 | 0.023 | 9.22*10-4 | 0.067 | 0.367 |
Omitting Study 6 | 1.88*10-4 | 7.55*10-4 | 9.51*10-4 | 0.023 | 0.165 |
Omitting Study 7 | 1.88*10-4 | 7.55*10-4 | 2.97*10-5 | 0.055 | 0.367 |
Omitting Study 8 | 1.90*10-4 | 7.55*10-4 | 9.51*10-4 | 0.023 | 0.165 |
Omitting Study 9 | 2.16*10-6 | 0.023 | 9.22*10-4 | 0.023 | 0.367 |
Study 1: Cervical Squamous Cell Carcinoma vs. Normal .Biewenga Cervix, Gynecol Oncol, 2008
Study 2: Cervical Cancer vs. Normal. Pyeon Multi-cancer, Cancer Res, 2007
Study 3: Cervical Adenocarcinoma vs. Normal. Scotto Cervix, Genes Chromosomes Cancer, 2008
Study 4: Cervical Squamous Cell Carcinoma vs. Normal. Scotto Cervix, Genes Chromosomes Cancer, 2008
Study 5: Cervical Squamous Cell Carcinoma vs. Normal. Scotto Cervix 2, Genes Chromosomes Cancer, 2008
Study 6: Cervical Keratinizing Squamous Cell Carcinoma vs. Normal. TCGA Cervix, No Associated Paper, 2012
Study 7: Cervical Non-Keratinizing Squamous Cell Carcinoma vs. Normal. TCGA Cervix, No Associated Paper, 2012
Study 8: Cervical Squamous Cell Carcinoma vs. Normal. TCGA Cervix, No Associated Paper, 2012
Study 9: Cervical Squamous Cell Carcinoma Epithelia vs. Normal. Zhai Cervix, Cancer Res, 2007.
PGene: The p-Value for a gene and is the p-Value for the median-ranked analysis